Vermillion Sets First Quarter 2013 Conference Call for Wednesday, May 15, 2013
AUSTIN, Texas, May 1, 2013
AUSTIN, Texas, May 1, 2013 /PRNewswire/ --Vermillion, Inc. (NASDAQ: VRML), a
molecular diagnostics company focused on gynecologic cancers and women's
health, will hold a conference call on Wednesday, May 15, 2013, at 4:30 p.m.
Eastern time to discuss results for the first quarter ended March 31, 2013.
Financial results will be issued in a press release prior to the call.
Vermillion's President and CEO Thomas McLain will host the call, followed by a
question and answer period.
Date: Wednesday, May 15, 2013
Time: 4:30 p.m. Eastern time (3:30 p.m. Central time)
Dial-In number: 1-800-709-0218
Conference ID: 21656230
The conference call will be webcast live and available for replay via the
investor section of the company's website at www.vermillion.com.
Please call the conference telephone number 5-10 minutes prior to the start
time. An operator will register your name and organization. If you have any
difficulty connecting with the conference call, please contact Liolios Group
A replay of the call will be available approximately two hours after the call
through May 29, 2013.
Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay ID: 21656230
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and
commercialization of novel high-value diagnostic tests that help physicians
diagnose, treat and improve outcomes for patients. Vermillion, along with its
prestigious scientific collaborators, has diagnostic programs in oncology,
vascular medicine and women's health. Additional information about Vermillion
can be found at www.vermillion.com.
Investor Relations Contact:
Liolios Group, Inc.
SOURCE Vermillion, Inc.
Press spacebar to pause and continue. Press esc to stop.